Core Viewpoint - Gongdong Medical's stock price has decreased by 2.69% to 19.9 yuan, with a current market capitalization of 4.388 billion yuan, ranking 86th in the medical device sector and 3636th in the A-share market [1] Shareholder Changes - As of June 30, 2025, the number of shareholders for Gongdong Medical was 9,870, an increase of 10.79% from March 31, 2025, with an average shareholding of 22,300 shares per account, resulting in an average market value of 424,200 yuan [2][5] Performance Disclosure Highlights - Gongdong Medical's mid-year report for 2025 shows a main revenue of 557 million yuan, a year-on-year increase of 0.58%, while the net profit attributable to shareholders decreased by 47.16% to 50.349 million yuan. The second quarter revenue was 292 million yuan, up 3.78% year-on-year, but the net profit dropped by 54.3% to 22.937 million yuan [3][5] Company Announcements Summary - The third board meeting of Gongdong Medical on August 25, 2025, approved several proposals, including the cancellation of the supervisory board and amendments to the company’s articles of association. A temporary shareholders' meeting is scheduled for September 18, 2025, to discuss these changes, with the supervisory board's responsibilities to be transferred to the audit committee of the board [4][5]
每周股票复盘:拱东医疗(605369)Q2净利降54.3%